Dalingo 82.5 mg
Dalingo 82.5 mg is a medicine authorised by Swissmedic under authorisation number 69956. The authorisation holder is Gebro Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 07 October 2025 and the authorisation is limited until 06 October 2030. ATC code N02BF02 places the medicine in the group Analgesics.
| Authorisation number | 69956 |
|---|---|
| Name | Dalingo 82.5 mg |
| Full name | Dalingo 82.5 mg, Retardtabletten |
| Authorisation holder | Gebro Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N02BF02 |
| First authorisation | 07 October 2025 |
| Authorisation validity | 06 October 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Dalingo 82.5 mg, Retardtabletten | B | 07 October 2025 |
| 2 | Dalingo 165 mg, Retardtabletten | B | 07 October 2025 |
| 3 | Dalingo 330 mg, Retardtabletten | B | 07 October 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 2 | 3 x 30 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 7 | 30 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 8 | 90 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 3 | 30 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 4 | 3 x 30 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 9 | 30 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 10 | 90 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 5 | 30 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 6 | 3 x 30 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 11 | 30 | Tablette(n) | N02BF02 | 01.07.1. | B |
| 12 | 90 | Tablette(n) | N02BF02 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Dalingo 82.5 mg authorised in Switzerland?
Yes. Dalingo 82.5 mg is authorised by Swissmedic under authorisation number 69956, data as of 01 September 2026. The authorisation is limited until 06 October 2030.
Which dispensing category does Dalingo 82.5 mg have?
Dalingo 82.5 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Dalingo 82.5 mg?
The authorisation holder is Gebro Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.